This CAR-T-7 cells therapy

N/A

Report date: 2024/11/25 20:00:28

Base Information

Drug NameThis CAR-T-7 cells therapy
Drug Alias NameAllogeneic CAR-T Targeting CD7Allogeneic Anti-CD7 CAR T CellsThisCART 7This CAR-T-7 cells
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-CD7
TargetsT-cell antigen CD7
Therapy Area/IndicationsLymphoma, T-CellPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesFundamenta Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFundamenta Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsLymphoma, T-CellPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma

Other Information

ATC CodeN/A
Related LinksN/A